MR
Moez Rajabali Rahemtulla Daya
About Moez Rajabali Rahemtulla Daya
Data last updated:
Moez Rajabali Rahemtulla Daya is a Nominee Director at Epigeneres Biotech Private Limited (since 2022). The company operates in Life Sciences. Epigeneres Biotech Private Limited reported revenue of ₹7.42 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Epigeneres Biotech Private Limited U29253MH2012PTC230235 | Nominee Director | 10 Jan 2022 | 2012 | ₹7.42 Cr (FY 2025) | Active |
Board colleagues of Moez Rajabali Rahemtulla Daya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amish Tripathi | 06932791 | Epigeneres Biotech Private Limited | Director |
| Anish Tripathi | 03383586 | Epigeneres Biotech Private Limited | Managing Director |
| Ashish Vinaykumar Tripathi | 06941116 | Epigeneres Biotech Private Limited | Director |
| Bhavna Roy | 03214372 | Epigeneres Biotech Private Limited | Director |
| Krishnan Venkata Challam | 00034473 | Epigeneres Biotech Private Limited | Director |
| Sanjay Pravinchandra | 03033677 | Epigeneres Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Moez Rajabali Rahemtulla Daya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Moez Rajabali Rahemtulla Daya
Moez Rajabali Rahemtulla Daya currently holds 1 directorship: Epigeneres Biotech Private Limited (Nominee Director, since 10 Jan 2022, revenue ₹7.42 Cr (FY 2025)).
Moez Rajabali Rahemtulla Daya was first appointed on 10 Jan 2022 as Nominee Director at Epigeneres Biotech Private Limited.
The current boards of Moez Rajabali Rahemtulla Daya's companies include Amish Tripathi (Epigeneres Biotech Private Limited), Anish Tripathi (Epigeneres Biotech Private Limited), Ashish Vinaykumar Tripathi (Epigeneres Biotech Private Limited), Bhavna Roy (Epigeneres Biotech Private Limited), Krishnan Venkata Challam (Epigeneres Biotech Private Limited), Sanjay Pravinchandra (Epigeneres Biotech Private Limited).